The United States Food and Drug Administration (FDA) approved the manufacturing and mass distribution of the blood thinning agent, Xarelto, back in 2011. It is also known by the name of its most potent and active ingredient, rivaroxaban. Since then, it has gained popularity all over the world – used commonly as a preventative measure against deep vein thrombosis (DVT) for people undergoing or who have undergone hip or knee replacement surgery. Worldwide, its sales amount up to $1 billion.
Unfortunately, there are unforeseen consequences to this anticoagulant drug that many of the people who had taken it were completely unaware of. Some patients experience discoloration in their urine or stool, sometimes even finding blood in them. Muscle weakness and fatigue are also symptoms of side effects that are much more serious that meets the eye. Many patients, according to the website of Williams Kherkher, have filed legal action against the manufacturers and claim that the drug caused severe gastrointestinal bleeding or brain hemorrhaging as a result of taking Xarelto.
Internal bleeding is not as easily spotted as an open flesh wound. These injuries are often brought to attention after careful examination. If an organ – such as the brain, the heart, the stomach – has its blood flow altered due to the presence of the bleeding, the organ could cease to function entirely. Brain hemorrhaging, for example, is caused by a ruptured vein in the brain that then surrounds the organ with blood, thereby tending to cause spasms or strokes.
There have been claims from the victims of these drugs (after study and investigation) that the manufacturers, Bayer and Johnson & Johnson, through Janssen Pharmaceuticals, were aware of these side effects but failed to label the products or inform patients of these possibly disabling and lethal side effects. Manufacturers of drugs like these need to be held legally accountable for defects found in their pharmaceuticals. It is then recommended that experienced legal representation is sought immediately if one has been found in a similar, Xarelto-born situation.